The Journal of Organic Chemistry
Article
5′-Methyl HPIP (3). Eluent: CHCl3/hexane = 5:1. Further
recrystallization from ethanol afforded white crystal (413 mg, 39%):
mp 150.9−151.2 °C; H NMR (CDCl3, 400 MHz) δ 12.48 (1H, s,
Calcd for C14H12N2O: C,74.98; H,5.39; N,12.49. Found: C,75.19;
H,5.26; N,12.42.
6-Chloro HPIP (8). Purification by a silica gel column chromatog-
1
OH), 8.14 (1H, d, J = 6.6 Hz, 5-H), 7.85 (1H, s, 3-H), 7.57 (1H, t, J =
4.9 Hz, 8-H), 7.39 (1H, d, J = 1.6 Hz, 6′-H), 7.22 (1H, ddd, J = 9.1,
6.9, 1.4 Hz, 7-H), 7.04 (1H, dd, J = 8.2, 1.6 Hz, 4′-H), 6.94 (1H, d, J =
8.2 Hz, 3′-H), 6.84 (1H, td, J = 7.0, 1.2 Hz, 6-H), 2.32 (3H, s, CH3);
13C NMR (CDCl3, 100 MHz) δ 155.1, 145.4, 143.4, 130.4, 127.9,
125.9, 125.3, 125.0, 117.4, 116.7, 115.7, 113.1, 106.6, 20.6. Anal. Calcd
for C14H12N2O: C,74.98; H,5.39; N,12.49%. Found: C,75.02; H,5.35;
N,12.34%.
raphy (CHCl3) and recrystallization from dimethyl sulfoxide yielded 8
1
as white solid (1.26 g, 76%): mp 197.6−198.5 °C; H NMR (CDCl3,
400 MHz) δ 12.41 (1H, s, OH), 8.19 (1H, dd, J = 1.8, 0.9 Hz, 5-H),
7.83 (1H, d, J = 0.7 Hz, 3-H), 7.58−7.52 (2H, m, 6′,8-H), 7.23−7.27
(1H, m, 4′-H), 7.20 (1H, dd, J = 9.5, 1.9 Hz, 7-H), 7.04 (1H, dd, J =
8.2, 1.1 Hz, 3′-H), 6.89 (1H, ddd, J = 8.1, 6.8, 0.9 Hz, 5′-H); 13C NMR
(CDCl3, 100 MHz) δ 157.2, 146.3, 141.9, 130.0, 126.5, 125.8, 123.2,
121.3, 119.1, 117.8, 117.0, 115.7, 107.1. Anal. Calcd for C13H9ClN2O:
C,63.81; H,3.71; N,11.45%. Found: C,63.70; H,3.67; N,11.31%.
6-Bromo HPIP (9). Purification by a silica gel column chromatog-
raphy (CHCl3) afforded 9 as white powder (166 mg, 72%): mp
5′-Chloro HPIP (4). Eluent: CHCl3/hexane = 2:1. Further
recrystallization from ethanol afforded white crystal (616 mg, 61%):
1
mp 188.0−188.8 °C; H NMR (CDCl3, 400 MHz) δ 12.74 (1H, s,
1
207.5−208.6 °C; H NMR (CDCl3, 400 MHz) δ 12.39 (1H, s, OH),
OH), 8.17 (1H, d, J = 7.1 Hz, 5-H), 7.87 (1H, s, 3-H), 7.61 (1H, d, J =
9.3 Hz, 8-H), 7.55 (1H, d, J = 2.7 Hz, 6′-H), 7.25−7.32 (1H, m, 7-H),
7.17 (1H, dd, J = 8.5, 2.5 Hz, 4′-H), 6.97 (1H, d, J = 8.8 Hz, 3′-H),
6.89 (1H, td, J = 6.8, 1.2 Hz, 6-H); 13C NMR (CDCl3, 100 MHz) δ
155.9, 144.1, 143.5, 129.3, 126.6, 125.5, 125.2, 123.5, 119.1, 117.4,
116.9, 113.4, 107.0. Anal. Calcd for C13H9ClN2O: C,63.81; H,3.71;
N,11.45%. Found: C,63.54; H,3.69; N,11.23%.
8.30 (1H, d, J = 1.1 Hz, 5-H), 7.83 (1H, s, 3-H), 7.57 (1H, dd, J = 7.7,
1.6 Hz, 6′-H), 7.49 (1H, t, J = 7.7 Hz, 8-H), 7.23−7.31 (2H, m, 4′,7-
H), 7.04 (1H, dd, J = 8.2, 1.1 Hz, 3′-H), 6.89 (1H, td, J = 7.4, 1.2 Hz,
5′-H); 13C NMR (CDCl3, 100 MHz) δ 157.3, 146.2, 141.9, 130.0,
128.6, 125.8, 125.3, 119.1, 117.8, 117.3, 115.7, 107.7, 106.9. Anal.
Calcd for C13H9BrN2O: C,54.00; H,3.14; N,9.69%. Found: C,53.82;
H,3.07; N,9.43%.
5′-Bromo HPIP (5). Eluent: CHCl3/hexane = 1:1. Further
6-Trifluoromethyl HPIP (10). Purification by a silica gel column
recrystallization from ethanol afforded white crystal (1.78 g, 60%):
1
chromatography (CHCl3) yielded 10 as white powder (423 mg, 44%):
mp 198.6−199.5 °C; H NMR (CDCl3, 400 MHz) δ 12.77 (1H, s,
1
mp 229.9−231.0 °C; H NMR (CDCl3, 400 MHz) δ 12.27(1H, s,
OH), 8.17 (1H, d, J = 7.1 Hz, 5-H), 7.86 (1H, s, 3-H), 7.69 (1H, d, J =
2.2 Hz6′-H), 7.60 (1H, d, J = 9.3 Hz, 8-H), 7.25−7.31 (2H, m, 4′,7-
H), 6.90 (2H, dd, J = 14.8, 7.7 Hz, 3′,6-H); 13C NMR (CDCl3, 100
MHz) δ 156.4, 143.9, 143.4, 132.1, 128.1, 125.6, 125.5, 119.5, 118.0,
116.8, 113.4, 110.6, 107.0. Anal. Calcd for C13H9BrN2O: C,54.00;
H,3.14; N,9.69%. Found: C,53.90; H,3.11; N,9.39%.
OH), 8.55(1H, s, 5-H), 7.97(1H, s, 3-H), 7.71(1H, d, J = 7.8 Hz, 8-H),
7.60(1H, dd, J = 6.4, 1.1 Hz, 6′-H), 7.40(1H, dd, J = 7.6, 1.1 Hz, 7-H),
7.27(1H, td, J = 5.6, 1.0 Hz, 4′-H), 7.05(1H, d, J = 7.2 Hz, 3′-H),
6.91(1H, td, J = 7.2, 1.1 Hz, 5′-H); 13C NMR (CDCl3, 100 MHz) δ
157.3, 147.2, 143.3, 130.4, 126.0, 124.3, 124.3, 121.2, 121.1, 119.2,
117.9, 117.4, 115.4, 107.9; HRMS (FAB/Double-focusing magnetic
sector), m/z Calcd. For C14H10F3N2O 279.0745, found 279.0737.
6-Cyano HPIP (11). Purification by a silica gel column
chromatography (CHCl3) and recrystallized from ethanol afforded
5′-Fluoro HPIP (6). Eluent: CHCl3. Further recrystallization from
ethanol afforded white crystal (346 mg, 44%): mp 161.6−162.6 °C;
1H NMR (CDCl3, 400 MHz) δ 12.51 (1H, s, OH), 8.18 (1H, d, J =
6.9 Hz, 5-H), 7.85 (1H, s, 3-H), 7.61 (1H, d, J = 9.2 Hz, 8-H), 7.25−
7.29 (2H, m, 6′,7-H), 6.93−6.99 (2H, m, 3′,4′-H), 6.89 (1H, t, J = 6.9
Hz, 6-H); 13C NMR (CDCl3, 100 MHz) δ 157.0, 154.7, 153.4, 144.4,
143.5, 125.5, 118.5, 116.9, 116.4, 116.2, 113.4, 111.5, 111.3, 107.1.
Anal. Calcd for C13H9FN2O: C,68.42; H,3.97; N,12.27%. Found:
C,68.16; H,3.94; N,12.16%.
1
11 as white solid (419 mg, 44%): mp 246.2−247.2 °C; H NMR
(CDCl3, 400 MHz) δ 12.06 (1H, s, OH), 8.61(1H, s, 5-H), 7.97(1H,
s, 3-H), 7.70(1H, d, J = 6.0 Hz, 8-H), 7.60(1H, dd, J = 5.3, 1.0 Hz, 6′-
H), 7.37(1H, dd, J = 5.8, 1.0 Hz, 7-H), 7.30(1H, td, J = 7.0, 1.0 Hz, 4′-
H), 7.05(1H, d, J = 5.3 Hz, 3′-H), 6.92(1H, td, J = 6.8, 1.0 Hz, 5′-H);
13C NMR (CDCl3, 100 MHz) δ 157.4, 147.8, 142.9, 131.0, 130.8,
126.1, 125.2, 119.4, 118.1, 117.7, 116.2, 115.0, 107.6, 99.6. Anal. Calcd
for C14H9N3O: C,71.48; H,3.86; N,17.86%. Found: C,71.79; H,3.83;
N,18.04%.
General Synthetic Procedure for 6-Substituted 2-(2′-
Hydroxyphenyl)imidazo[1,2-a]pyridine (6-Substituted HPIP).
An acetonitrile solution of 2-(bromoacetyl)anisol, 5-substituted 2-
amino-pyridine and NaHCO3 (2 equiv) was refluxed for 20 h. After
filtering off insoluble solid, the filtrate was evaporated, and the residue
was applied to a silica gel column (CHCl3/ethyl acetate =10:1) to
afforded 6-substituted 2-(2′-methoxyphenyl) imidazo[1,2-a]pyridine.
A dichloromethane solution of boron tribromide (1.0 M, 4 equiv) was
dropwise added to a cooled anhydrous dichloromethane solution of
well-dried 6-substituted 2-(2′-methoxyphenyl) imidazo[1,2-a]pyridine.
The reaction mixture was allowed to reach room temperature and
further stirred for 15 h. A saturated aqueous NaHCO3 was slowly
added with stirring, and then was separated with water and
chloroform. After washing the organic layer with saturated aqueous
NaHCO3 and water, and drying over Na2SO4, the organic layer was
evaporated to give crude product.
HPIP (1). Purification by recrystallization from ethanol (3.65 g,
43%): mp 142−143 °C; 1H NMR (CDCl3, 400 MHz) δ 12.70 (1H, s,
OH), 8.16 (1H, dd, J = 5.5, 1.1 Hz, 5-H), 7.88 (1H, s, 3-H), 7.60 (2H,
dd, J = 8.0, 1.4 Hz, 6′,8-H), 7.21−7.25 (2H, m, 4′,7-H), 7.04 (1H, dd, J
= 8.2, 1.1 Hz, 3′-H), 6.85−6.91 (2H, m, 5′,6-H); 13C NMR (CDCl3,
100 MHz) δ 157.3, 145.3, 143.4, 129.7, 125.7, 125.4, 125.2, 119.0,
117.7, 116.8, 116.2, 113.2, 106.7. Anal. Calcd for C13H10N2O: C,74.27;
H,4.79; N,13.33%. Found: C,74.02; H,4.81; N,13.30%.
4′-Methoxy HPIP (12). A chloroform (50 mL) solution of 2-acetyl-
5-methoxyphenol (1.22 g, 7.34 mmol) and copper(II) bromide (2.95
g, 13.2 mmol) was refluxed for 24 h. After cooling, filtering off
insoluble solid, evaporation of the filtrate yielded crude 2-
(bromoacetyl)-5-methoxyphenol, which was applied to a silica gel
column (ethyl acetate/hexane = 1:5; 50%). Then an acetonitrile (40
mL) solution of 2-(bromoacetyl)-5-methoxyphenol (869 mg, 3.55
mmol), 2-aminopyridine (334 mg, 3.55 mmol) and NaHCO3 (596
mg, 7.10 mmol) was refluxed for 20 h. After filtering off insoluble solid
and evaporation, the crude product was purified by a silica gel column
chromatography (ethyl acetate/hexane = 1:1). Recrystallization from
ethanol gave 12 as a white crystal (342 mg, 40%): mp 158.0−158.3
°C; 1H NMR (CDCl3, 400 MHz) δ 12.87 (1H, s, OH), 8.14 (1H, dt, J
= 6.7, 1.1 Hz, 5-H), 7.76 (1H, s, 3-H), 7.57 (1H, dd, J = 9.2, 0.9 Hz, 8-
H), 7.49 (1H, d, J = 8.2 Hz, 6′-H), 7.21 (1H, ddd, J = 8.9, 6.9, 1.1 Hz,
7-H), 6.84 (1H, td, J = 6.9, 1.4 Hz, 6-H), 6.59 (1H, d, J = 2.7 Hz, 3′-
H), 6.48 (1H, dd, J = 8.7, 2.7 Hz5′-H), 3.83 (3H, s, OCH3); 13C NMR
(CDCl3, 100 MHz) δ 161.0, 158.9, 145.4, 143.3, 126.6, 125.2, 124.9,
116.5, 112.9, 109.3, 106.5, 105.5, 101.7, 55.3. Anal. Calcd for
C14H12N2O2: C,69.99; H,5.03; N,11.66%. Found: C,70.17; H,5.03;
N,11.50%.
6-Methyl HPIP (7). Purification by recrystallization from ethanol
(820 mg, 38%): mp 180.6−181.5 °C; 1H NMR (CDCl3, 400 MHz) δ
7.92(1H, s, 5-H), 7.77(1H, s, 3-H), 7.57(1H, dd, J = 6.0, 1.0 Hz, 6′-
H), 7.49(1H, d, J = 9.2 Hz, 8-H), 7.21(1H, td, J = 5.4, 1.0 Hz, 4′-H),
7.02−09(2H, m, 3′,7-H), 6.87(1H, td, J = 4.8, 0.8 Hz, 5′-H), 2.34(s,
3H, CH3); 13C NMR (CDCl3, 100 MHz) δ 157.3, 145.0, 142.4, 129.4,
128.3, 125.6, 123.1, 122.8, 118.9, 117.6, 116.4, 116.1, 106.4, 18.2. Anal.
5′-Methyl-6-chloro HPIP (13). A chloroform (50 mL) solution of 2-
acetyl-4-methylphenol (3.00 g, 20.0 mmol) and copper(II) bromide
(6.70 g, 30.0 mmol) was refluxed for 22 h. After cooling, filtering off
insoluble solid, evaporation of the filtrate yielded crude 2-
(bromoacetyl)-4-methylphenol, which was applied to a silica gel
column (CHCl3/hexane = 1:1; 66%). Then an acetonitrile (30 mL)
F
dx.doi.org/10.1021/jo302711t | J. Org. Chem. XXXX, XXX, XXX−XXX